# FDA Inspection 602054 - Nasr,Samya M.D. - August 25, 2009

Source: https://www.keypedia.com/records/fda_inspections/nasrsamya-md/b5383ae1-26d2-420d-b1a1-98f3d0dafad6
Source feed: FDA_Inspections

> FDA Inspection 602054 for Nasr,Samya M.D. on August 25, 2009. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 602054
- Company Name: Nasr,Samya M.D.
- Inspection Date: 2009-08-25
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 742466 - 2011-09-01](https://www.keypedia.com/records/fda_inspections/nasrsamya-md/38f266a3-43e5-464a-83d7-4d00a68c2201)

Company: https://www.keypedia.com/companies/nasrsamya-md/22689e42-11f7-4da4-b197-9fa5cc153533

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c